Linzhi Zhang
Overview
Explore the profile of Linzhi Zhang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
79
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
He Q, Wang M, Zhu H, Xiao Y, Wen R, Liu X, et al.
Front Neurol
. 2025 Feb;
15:1487248.
PMID: 39949532
Objective: This study aimed to develop and validate a nomogram for predicting the risk of 3 months adverse outcomes among young adults with acute ischemic stroke (AIS). Methods: Patients aged...
2.
Shao F, Sun X, Yu Q, Wang K, Sun C, Wang Q, et al.
Int J Biol Macromol
. 2024 Nov;
282(Pt 6):137474.
PMID: 39528198
Overexpression of glial fibrillary acidic protein (GFAP) in activated astrocytes following spinal cord injury is closely associated with glial scar formation, which harms axonal regrowth. In this study, we prepared...
3.
Yu Q, Zhang L, Wang Z, Wang Q, Sun X, Deng W, et al.
Phytomedicine
. 2024 Oct;
135:156173.
PMID: 39471736
Background: Mesenchymal stem cells (MSCs) possess the capability to mitigate multiorgan failure (MOF) and reduce mortality rates in sepsis. However, their survival is significantly limited due to oxidative stress responses...
4.
Wen R, Wang M, Bian W, Zhu H, Xiao Y, Zeng J, et al.
Front Neurol
. 2024 Sep;
15:1408457.
PMID: 39314867
Background: This investigation seeks to ascertain the efficacy of various machine learning models in forecasting early neurological deterioration (END) following thrombolysis in patients with acute ischemic stroke (AIS). Methods: Employing...
5.
He Q, Wang M, Zhu H, Xiao Y, Wen R, Liu X, et al.
Front Aging Neurosci
. 2024 Sep;
16:1450863.
PMID: 39280700
Background: We aimed to use lactate dehydrogenase (LDH) as a marker of inflammation burden and quantify post-stroke inflammation's direct and indirect effect on functional disability. Methods: We analyzed 5,129 patients...
6.
Zhang L, Wang Z, Sun X, Rong W, Deng W, Yu J, et al.
Cell Immunol
. 2024 Jun;
401-402:104840.
PMID: 38880071
Sepsis is characterized by an exacerbated inflammatory response, driven by the overproduction of cytokines, a phenomenon known as a cytokine storm. This condition is further compounded by the extensive infiltration...
7.
The applications of 3D printing in wound healing: The external delivery of stem cells and antibiosis
Yu Q, Wang Q, Zhang L, Deng W, Cao X, Wang Z, et al.
Adv Drug Deliv Rev
. 2023 Apr;
197:114823.
PMID: 37068658
As the global number of chronic wound patients rises, the financial burden and social pressure on patients increase daily. Stem cells have emerged as promising tissue engineering seed cells due...
8.
Lei J, Yang S, Chen B, Zhang L, Yan T, Yang G, et al.
J Hepatocell Carcinoma
. 2023 Mar;
10:357-367.
PMID: 36891505
Background: Tyrosine kinase inhibitors (TKI) combined with programmed cell death-1 (PD-1) inhibitor is a potential treatment modality for patients with HCV-related unresectable hepatocellular carcinoma (uHCC). Methods: The participants of the...
9.
Yan T, Huang C, Peng C, Duan X, Ji D, Duan Y, et al.
Ann Transl Med
. 2023 Feb;
11(2):109.
PMID: 36819518
Background: At present, there are no definitive optimal treatment options for patients with hepatocellular carcinoma (HCC) following first-line treatment failure. To maximize the survival benefit of patients, we compared the...
10.
Yang X, Chen B, Wang Y, Wang Y, Long J, Zhang N, et al.
Hepatol Int
. 2023 Feb;
17(3):709-719.
PMID: 36753026
Introduction: Combining lenvatinib with a programmed cell death protein-1 (PD-1) inhibitor has been explored for the treatment of un-resectable hepatocellular carcinoma (uHCC). This study aimed to investigate the real-world efficacy...